Drug profile · INN
imlunestrant tosylate
INLURIYO
imlunestrant tosylate (INLURIYO) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Drug details — imlunestrant tosylate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
imlunestrant tosylate (INLURIYO) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is imlunestrant tosylate?
imlunestrant tosylate (INLURIYO) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for imlunestrant tosylate?
INLURIYO is a marketed brand name for imlunestrant tosylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of imlunestrant tosylate?
imlunestrant tosylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.